| Judy Wells, | |
|
350 Henry Clay Blvd., Lexington, KY 40502 | |
| (859) 268-4545 | |
| (859) 269-1857 |
| Full Name | Judy Wells |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 350 Henry Clay Blvd., Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043430952 | NPI | - | NPPES |
| 220 | Other | KY | FIRST STEPS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1288 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Judy Wells, 350 Henry Clay Blvd., Lexington, KY 40502 Ph: (859) 268-4545 | Judy Wells, 350 Henry Clay Blvd., Lexington, KY 40502 Ph: (859) 268-4545 |
News Archive
Perrigo Company plc announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex 600mg Extended-Release tablets.
An inexpensive, routine blood test could hold the key to why some patients with congestive heart failure do well after being discharged from the hospital and why others risk relapse, costly readmission or death within a year, new Johns Hopkins research suggests.
Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great interest to economists, who have devised theories about how we assign values to our options and use those values to make decisions.
Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.
› Verified 6 days ago
Kathleen Shelton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3365 Hunting Hills Ct, Lexington, KY 40515 Phone: 859-576-4807 | |
Mrs. Jessica Sanders Roberts, M.A, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Mrs. Erica Keller Musgrave, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 882 Mcmeekin Pl, Lexington, KY 40502 Phone: 859-619-5259 | |
Melena Dailey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2412 Greatstone Pt, Lexington, KY 40504 Phone: 859-224-4081 | |
Barbara Shaw, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Mason Headley Rd, Lexington, KY 40504 Phone: 859-276-1083 | |
Christina Johnson, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1165 Monarch St, Lexington, KY 40513 Phone: 859-335-7980 | |
Mrs. Amanda Moore Chastain, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2035 Regency Rd, Suite 5, Lexington, KY 40503 Phone: 859-402-1553 Fax: 859-402-1553 |